Shukra Pharmaceuticals Ltd

BSE :524632 NSE :- Sector : Pharmac..
180.85
Change: 3.50(1.97%)
52 week Low
30.79
52 week High
180.85
Day low
180.85
Day high
180.85
Prev Close
177.35
Open
180.85
6M return
82.95%
1Y return
441.31%
MCap(Rs. in Cr.)
776.58
Total Volume
71,861
Face Value : 10
Listed Since
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
53.74
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
3.30
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
14.59
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
100%
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0.14

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales
263.93%

Sales Industry Avg
32.81%

PAT
2,372.00%

PAT Industry Avg
29.29%

Sep 2024
( in Cr.)
Jun 2024
( in Cr.)
Mar 2024
( in Cr.)
Dec 2023
( in Cr.)
FY 2024
( in Cr.)
Sales5.563.1810.8818.8974.57
Gross Profit1.571.465.7410.0421.93
Operating Profit00000
Profit Before Tax0.830.765.259.5219.89
Tax0.290.271.260.101.35
Profit After Tax0.540.493.999.4218.54
No data available
5%
2023
10%
2024 2025
2026


Relative to Sensex rtn in 3 year
15,850.79%

Relative to Nifty rtn in 3 year
14,728.16%



1 Year (%)2 Year (%)3 Year (%)
Shukra Pharma.441undefinedundefined
Bse Sensex92829
Nifty 5093031

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Shukra Pharma.
180.85
Change: 3.50 (1.97%)
1 Year return
441.31%
Risk (Std Dev)
0.46%
PE Ratio
53.74
MCap( in Cr.)
776.58
Oxygenta Pharma
82.53
Change: 1.41 (1.74%)
1 Year return
138.94%
Risk (Std Dev)
0.28%
PE Ratio
NM
MCap( in Cr.)
300.01
Pharmaids Pharma
83.31
Change: 1.63 (2.00%)
1 Year return
27.78%
Risk (Std Dev)
0.17%
PE Ratio
NM
MCap( in Cr.)
288.07
Everest Organics
279.00
Change: -4.25 (-1.50%)
1 Year return
97.87%
Risk (Std Dev)
0.34%
PE Ratio
NM
MCap( in Cr.)
226.60
Syschem (India)
50.50
Change: 0.80 (1.61%)
1 Year return
-16.25%
Risk (Std Dev)
0.15%
PE Ratio
NM
MCap( in Cr.)
198.12
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 5,41,305.00 with a Gain of 441.31%

Corporate Action

Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.

D
2023
B
D
2024
2025

News

Stay tuned to the latest developments and happenings in the company.

Shukra Pharmaceuticals to hold board meeting

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 January 2025.Powered by Capital Market - Live Ne....

06 Jan 2025 09:21

Shukra Pharmaceuticals standalone net profit declines 88.54% in the September 2024 quarter

Net profit of Shukra Pharmaceuticals declined 88.54% to Rs 0.54 crore in the quarter ended September 2024 as against Rs 4.71 crore during the previous....

15 Nov 2024 07:39

Shukra Pharmaceuticals to discuss results

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live N....

08 Nov 2024 17:22

Shukra Pharmaceuticals schedules board meeting

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 September 2024.Powered by Capital Market - Live....

24 Sep 2024 10:28

Shukra Pharmaceuticals standalone net profit rises 16.67% in the June 2024 quarter

Net profit of Shukra Pharmaceuticals rose 16.67% to Rs 0.49 crore in the quarter ended June 2024 as against Rs 0.42 crore during the previous quarter ....

13 Aug 2024 07:28

Shukra Pharmaceuticals standalone net profit rises 0.25% in the March 2024 quarter

Net profit of Shukra Pharmaceuticals rose 0.25% to Rs 3.99 crore in the quarter ended March 2024 as against Rs 3.98 crore during the previous quarter ....

30 May 2024 07:39

View More
Subscribe for our
newsletter
Open Account Now